nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Adenosine: Use as a Diagnostic and Therapeutic Tool
|
Jamie Beth Conti |
|
2000 |
4 |
3 |
p. 227-232 6 p. |
artikel |
2 |
Amiodarone Oral
|
Denis Roy |
|
2000 |
4 |
3 |
p. 262-269 8 p. |
artikel |
3 |
Antiarrhythmic Impact of Anti-Ischemic, Anti-Failure and Other Cardiovascular Strategies
|
Michael J. Reiter |
|
2000 |
4 |
3 |
p. 194-205 12 p. |
artikel |
4 |
Beta-Blockers
|
Jeffery L. Anderson |
|
2000 |
4 |
3 |
p. 301-308 8 p. |
artikel |
5 |
Bretylium Tosylate (UDATE2000)
|
Ernest L. Fallen |
|
2000 |
4 |
3 |
p. 235-236 2 p. |
artikel |
6 |
Calcium Channel Blockers
|
D. George Wyse |
|
2000 |
4 |
3 |
p. 309-312 4 p. |
artikel |
7 |
Classification of Antiarrhythmic Drugs
|
Michael R. Rosen |
|
2000 |
4 |
3 |
p. 181-185 5 p. |
artikel |
8 |
Clinical Value of d,l-sotalol: Overview of Recent Trials
|
Joachim R. Ehrlich |
|
2000 |
4 |
3 |
p. 296-300 5 p. |
artikel |
9 |
Disopyramide Phosphate
|
Malcolm M. Kirk |
|
2000 |
4 |
3 |
p. 270-272 3 p. |
artikel |
10 |
Dofetilide for Atrial Flutter and Fibrillation
|
P.E. Bloch Thomsen |
|
2000 |
4 |
3 |
p. 273-277 5 p. |
artikel |
11 |
Drugs for the Prevention and Control of Syncope
|
Jean T. Barbey |
|
2000 |
4 |
3 |
p. 317-320 4 p. |
artikel |
12 |
Esmolol and Other Intravenous Beta-Blockers
|
William H. Maisel |
|
2000 |
4 |
3 |
p. 240-242 3 p. |
artikel |
13 |
Flecainide Acetate2000 Update
|
Rodolphe Ruffy |
|
2000 |
4 |
3 |
p. 278-280 3 p. |
artikel |
14 |
Interactions Between Implantable Devices and Antiarrhythmic Drugs
|
Arnold Pintér |
|
2000 |
4 |
3 |
p. 222-226 5 p. |
artikel |
15 |
Investigational Class III Antiarrhythmic Agents
|
Philip T. Sager |
|
2000 |
4 |
3 |
p. 321-327 7 p. |
artikel |
16 |
Is Digoxin an Antiarrhythmic Drug?
|
T. David Gbadebo |
|
2000 |
4 |
3 |
p. 313-316 4 p. |
artikel |
17 |
IV Amiodarone and Evidence-Based Pharmacologic Therapy During Cardiac Arrest
|
Jeffrey R. Balser |
|
2000 |
4 |
3 |
p. 233-234 2 p. |
artikel |
18 |
Mechanisms of Antiarrhythmic Drug Actions
|
Stanley Nattel |
|
2000 |
4 |
3 |
p. 186-189 4 p. |
artikel |
19 |
Moricizine
|
Susan Brode |
|
2000 |
4 |
3 |
p. 281-283 3 p. |
artikel |
20 |
Oral Antiarrhythmic Drugs Used for Arrhythmia Prevention
|
Bengt Herweg |
|
2000 |
4 |
3 |
p. 255-261 7 p. |
artikel |
21 |
Oral Procainamide
|
Eric J. Rashba |
|
2000 |
4 |
3 |
p. 284-287 4 p. |
artikel |
22 |
Overview of Lidocaine
|
David Newman |
|
2000 |
4 |
3 |
p. 248-250 3 p. |
artikel |
23 |
Proarrhythmia: Classification, Incidence, Risk Factors, Monitoring, Prevention and Management
|
Augustus O. Grant |
|
2000 |
4 |
3 |
p. 206-211 6 p. |
artikel |
24 |
Proarrhythmia Related to Prolongation of Repolarization: Mechanisms, Monitoring, Prevention,and Management
|
Craig T. January |
|
2000 |
4 |
3 |
p. 212-216 5 p. |
artikel |
25 |
Proarrhythmia Related to Sodium Channel Blockade II: Postulated Mechanisms of Brugada Syndrome and Their Possible Involvement in Class IC Drug-Induced Ventricular Arrhythmias During Ischemia
|
Hanno L. Tan |
|
2000 |
4 |
3 |
p. 217-221 5 p. |
artikel |
26 |
Propafenone
|
Jose A. Joglar |
|
2000 |
4 |
3 |
p. 288-291 4 p. |
artikel |
27 |
Quinidine in Atrial Fibrillation and Ventricular Tachycardia
|
Andrew A. Grace |
|
2000 |
4 |
3 |
p. 292-295 4 p. |
artikel |
28 |
The Role of Calcium Channel Blockers in Restorationand Maintenance of Sinus Rhythm in Patients with Atrial Fibrillation
|
Bas A. Schoonderwoerd |
|
2000 |
4 |
3 |
p. 237-239 3 p. |
artikel |
29 |
Update on Intravenous Ibutilide
|
Bruce S. Stambler |
|
2000 |
4 |
3 |
p. 243-247 5 p. |
artikel |
30 |
Update on the Use of Magnesium as an Antiarrhythmic Drug
|
Terence John Campbell |
|
2000 |
4 |
3 |
p. 251-254 4 p. |
artikel |
31 |
Using Antiarrhythmic Drugs: Administration,Pharmacokinetics, and Compliance
|
Katherine T. Murray |
|
2000 |
4 |
3 |
p. 190-193 4 p. |
artikel |